top of page

The FDA has expanded the indication for TMS for patients as young as 15 years of age.

Writer's picture: Benjamin GreenzweigBenjamin Greenzweig

Updated: Nov 25, 2024


Can A New FDA-Cleared Treatment Help Address Depression in Adolescents? Read Now on Vouge

Comments


bottom of page